Successful mobilization using a combination of plerixafor and G-CSF in pediatric patients who failed previous chemomobilization with G-CSF alone and possible complications of the treatment

Peripheral blood stem cell (PBSC) mobilization, which uses plerixafor (AMD 3100), a newly developed specific inhibitor of the CXCR4 receptor, in combination with granulocyte-colony stimulating factor(G-CSF), has been shown to enhance the stem cell mobilization in adult patients, but pediatric data a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Kyung Taek, Kang, Hyoung Jin, Kim, Nam Hee, Kim, Min Sun, Lee, Ji Won, Kim, Hyery, Park, Kyung Duk, Shin, Hee Young, Ahn, Hyo Seop
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361468/
https://www.ncbi.nlm.nih.gov/pubmed/22458355
http://dx.doi.org/10.1186/1756-8722-5-14

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3361468/
https://www.ncbi.nlm.nih.gov/pubmed/22458355
http://dx.doi.org/10.1186/1756-8722-5-14

Ejemplares similares